MarketPeel
Insider Trading Intelligence
EL

Eric Lefebvre

PLRX
CHIEF MEDICAL OFFICER · PLIANT THERAPEUTICS, INC. · CIK 0001614741
FILING MIX · LIFETIME43%/57%
BUYS
12
SELLS
16
TOTAL VALUE
$5.13M
COMPANIES
1
ACTIVE SINCE
Dec 2020
HOLDINGS NOW
240,224
AVG SELL PX
$25.85
TRADE KIND
SHOWING 28 / 28
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
16 backtested trades · 8 horizons · 2 pending
Forward-return performance of every backtestable P/S trade by Eric Lefebvre, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d16+56.25%+0.54%+0.84%-0.30%-1.34%
14d16+75.00%-4.70%+1.83%-6.53%-7.33%
30d16+62.50%-9.94%+2.71%-12.65%-13.18%
60d16+75.00%-11.86%+3.84%-15.70%-25.46%
90d16+62.50%-8.17%+3.81%-11.98%-21.28%
180d16+62.50%-22.70%+11.45%-34.15%-44.47%
1y16+100.00%-53.97%+15.04%-69.01%-65.10%
2y16(2 pending)+100.00%-46.91%+28.31%-75.22%-61.46%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
PLRX · 240,224 shares · as of Jan 23, 2025
060,056120,112180,168240,22420212022202320242025SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
FLOW · 12 buys / 16 sellsCOVERAGE · 18 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
PLRX
PLIANT THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
91,30091,300Jan 23, 2025Jan 27, 2025View →
PLRX
PLIANT THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
45,650240,224Jan 23, 2025Jan 27, 2025View →
PLRX
PLIANT THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
18,478$11.20$207.0K194,574Jan 17, 2025Jan 22, 2025View →
PLRX
PLIANT THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
12,319$11.56$142.4K213,052Jul 10, 2024Jul 12, 2024View →
PLRX
PLIANT THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
24,063225,371Jul 9, 2024Jul 11, 2024View →
PLRX
PLIANT THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
42,900199,820Jan 23, 2024Jan 24, 2024View →
PLRX
PLIANT THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
85,80085,800Jan 23, 2024Jan 24, 2024View →
PLRX
PLIANT THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
10,295$17.23$177.4K156,920Jan 17, 2024Jan 19, 2024View →
PLRX
PLIANT THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
22,321$18.01$402.0K167,215Jul 17, 2023Jul 19, 2023View →
PLRX
PLIANT THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
43,750189,536Jul 14, 2023Jul 18, 2023View →
PLRX
PLIANT THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
11,245$26.52$298.2K145,786Mar 30, 2023Apr 3, 2023View →
PLRX
PLIANT THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
21,874157,031Mar 29, 2023Mar 31, 2023View →
PLRX
PLIANT THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
57,000133,926Jan 25, 2023Jan 27, 2023View →
PLRX
PLIANT THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
80,00080,000Jan 25, 2023Jan 27, 2023View →
PLRX
PLIANT THERAPEUTICS, INC.
SALE
Chief Medical Officer
67,500$34.48$2.33M76,926Jan 23, 2023Jan 25, 2023View →
PLRX
PLIANT THERAPEUTICS, INC.
SALE
Chief Medical Officer
10,887$19.10$208.0K144,426Dec 20, 2022Dec 21, 2022View →
PLRX
PLIANT THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
21,876155,313Dec 19, 2022Dec 21, 2022View →
PLRX
PLIANT THERAPEUTICS, INC.
SALE
Chief Medical Officer
5,000$25.05$125.2K133,437Oct 25, 2022Oct 27, 2022View →
PLRX
PLIANT THERAPEUTICS, INC.
SALE
Chief Medical Officer
3,000$20.00$60.0K138,436Jul 11, 2022Jul 13, 2022View →
PLRX
PLIANT THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
140,000140,000Jan 26, 2022Feb 2, 2022View →
PLRX
PLIANT THERAPEUTICS, INC.
SALE
Chief Medical Officer
22$30.23$665137,080Jun 18, 2021Jun 22, 2021View →
PLRX
PLIANT THERAPEUTICS, INC.
SALE
Chief Medical Officer
3,728$29.43$109.7K137,102Jun 18, 2021Jun 22, 2021View →
PLRX
PLIANT THERAPEUTICS, INC.
SALE
Chief Medical Officer
8,750$28.62$250.4K140,830Jun 18, 2021Jun 22, 2021View →
PLRX
PLIANT THERAPEUTICS, INC.
SALE
Chief Medical Officer
11,365$39.38$447.5K150,715Mar 18, 2021Mar 19, 2021View →
PLRX
PLIANT THERAPEUTICS, INC.
SALE
Chief Medical Officer
1,135$39.78$45.2K149,580Mar 18, 2021Mar 19, 2021View →
PLRX
PLIANT THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
73,25073,250Jan 23, 2021Jan 26, 2021View →
PLRX
PLIANT THERAPEUTICS, INC.
SALE
Chief Medical Officer
5,712$26.98$154.1K162,080Dec 18, 2020Dec 21, 2020View →
PLRX
PLIANT THERAPEUTICS, INC.
SALE
Chief Medical Officer
6,788$26.17$177.6K167,792Dec 18, 2020Dec 21, 2020View →
Other insiders · PLRX
Loading peer insiders…
About this filer
CIK 0001614741
ROLE
Chief Medical Officer
PRIMARY
PLRX
COMPANIES
1
ACTIVE SINCE
Dec 2020
MARKETPEEL · /INSIDER/0001614741DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback